163 filings
Page 2 of 9
6-K
fxns0j6 76r842f3ii
27 Nov 23
Immunoprecise Antibodies LTD. 6-K
8:31am
6-K
sk0n0tduvz5e20wch5qh
16 Nov 23
Report of Voting Results
5:13pm
6-K
s47a04ys
13 Nov 23
Immunoprecise Antibodies LTD. 6-K
8:50am
6-K
x14th97l7eq72y4op3kv
25 Oct 23
BioStrand Unveils Groundbreaking Retrieval Augmented Generation (RAG)-Based LLM Platform Integrated with Patented HYFT Technology
8:01am
6-K
15yjpltqn ioqdlojqp
23 Oct 23
Immunoprecise Antibodies LTD. 6-K
8:01am
6-K
obwg lgk49l
20 Oct 23
Current report (foreign)
2:56pm
6-K
7z8hpml
26 Sep 23
Material Change Report
11:56am
6-K
guibfbdoe9p
25 Sep 23
Current report (foreign)
4:46pm
6-K
ps5opvl
19 Sep 23
Immunoprecise Antibodies LTD. 6-K
8:02am
6-K
er44jsg
18 Sep 23
Statement of Executive Compensation
2:47pm
6-K
yakwlcth46s
14 Sep 23
Current report (foreign)
8:02am
6-K
ptc2nhhhkql2n
14 Sep 23
Immunoprecise Antibodies LTD. 6-K
8:01am
6-K
vzpy42jvrlsvonstp0nr
12 Sep 23
Material Change Report
6:20pm
6-K
x6o5tk7i r128za
8 Sep 23
The Company to host an earnings conference call via webcast
8:30am
6-K
lyv0h2h
5 Sep 23
IPA appoints Barry A. Springer, Dirk Witters and Chris Buyse to the Board of Directors
8:14am
6-K
o4d3p1piuza3a16
15 Aug 23
Current report (foreign)
5:50pm
424B5
70nf2kk
15 Aug 23
Prospectus supplement for primary offering
5:47pm
6-K/A
rozzpukvt1a9gtc1
14 Aug 23
Current report (foreign) (amended)
4:38pm
6-K/A
m011saa7p0xxiu4
14 Aug 23
Current report (foreign) (amended)
4:29pm
6-K
vkqgjk6
9 Aug 23
Immunoprecise Antibodies LTD. 6-K
9:15am